No description available.

E-492, actinofuranone A, and JBIR-108 are natural compounds isolated from actinobacteria Streptomyces genus and can lead to the development of new pharmaceuticals as they have some biological interesting activities. Although the synthesis of these actinofuranones has been already published, this work brings new methods for the preparation of their fragments. The key step of the synthesis is enantioselective crotylboration of an aldehyde catalyzed by a chiral Brønsted acid and by which two centres of chirality are introduced in one step. The other crucial steps of the synthesis are composed of Ru-catalyzed alkene-alkene cross-metathesis and Pd- catalyzed Suzuki cross-coupling. Keywords: natural compound, enantioselective syntheses, crotylation, catalysis, actinofuranone fragment

The current methodologies of catalytic enantioselective allylation of aldehydes were studied on conjugated dienals and later on haloacrylaldehydes as the substrates. The resulting enantioenriched homoallylalcohols were prepared by reactions promoted either by commercial Brønsted acid catalysts or by Lewis base catalysts developed by our group, often with high enantio- and diastereoselectivities. Subsequently, the methodology was expanded on catalytic enantioselective crotylation and pentenylation reactions, practically unknown not only with these substrates. The applicability of this synthetic approach was demonstrated on preparation of several natural products or their intermediates.

Enzymes are some of nature's most powerful tools in chemical processes. However, their molecular complexity makes them difficult to synthesize and complicates their application in traditional organic synthesis. Peptides, a building block of enzymes, can be rapidly synthesized and have been used as a possible alternative in achieving enzyme-like catalysis. However, most peptide-based catalysts are limited in reaction-scope and are unable to incorporate traditional organic catalysts. We have designed a helical peptide scaffold capable of being functionalized with a wide variety of organocatalysts as well as transition-metal based catalysts. In order to understand how the peptide structure effects reactivity and selectivity we designed and studied a helical peptide functionalized with enamine and thiourea catalysts for the conjugate addition reaction of a variety of nitroolefins to cyclohexanone. By rationally engineering the peptide backbone, we were able to achieve up to 95%ee. Our studies emphasized the crucial role the peptide secondary structure plays in this reaction and its potential to serve as a general catalytic platform for future reaction development. Progress particularly toward the development of peptide scaffolds capable of binding transition-metals and performing organometallic catalysis is also described. Peptides are promising motifs in therapeutics. They are more specific and are able to bind to a larger range of targets than small-molecule based drugs while also having lower immunogenicity than larger biologic-based drugs. However, their poor in vivo stability is problematic for their more widespread use. Peptide stapling has been shown to increase peptide stability by covalently linking two ends of the peptide. Squaric esters are commonly used in conjugation chemistry and have shown to selectively react with primary amine nucleophiles, such as those on lysine sidechains. However, their potential to act as peptide stapling reagents has remained unexplored. We have developed a method whereby helical peptides can be stapled with squaric methyl ester on-resin. Peptides can be stapled at the i+1, i+4, and i+7 positions in good yields. The staple is also stable under the highly acidic conditions used to cleave the peptides from resin. Circular dichroism studies show that the staple is able to increase peptide helicity when compared with an unstapled control.